BERKELEY HEIGHTS, N.J., June 23, 2011 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA) announced that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide a company overview and update of recent clinical research on the Company's lead compounds, tesetaxel and oral gallium, at the 2011 BIO International Business Forum on Wednesday, June 29th at 10:45 AM EDT.
